Related Experiment Video
Updated: May 10, 2026
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Recommendations for Radiation Treatment in Pediatric Patients With Metastatic Rhabdomyosarcoma: Expert Consensus From
Leslie Chang1, Alison Cameron2, Blair M Murphy3
1Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.
Insights
International guidelines offer treatment recommendations for pediatric metastatic rhabdomyosarcoma (RMS). These consensus guidelines focus on radiation therapy for local control, aiding oncologists in managing this rare childhood cancer.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Sarcoma Research
Background:
- The International Soft Tissue Sarcoma Database Consortium (INSTRuCT) unites North American and European pediatric oncology groups.
- INSTRuCT aims to standardize treatment recommendations for pediatric sarcoma patients.
- Metastatic rhabdomyosarcoma (RMS) presents unique challenges in pediatric care.
Purpose of the Study:
- To develop international consensus guidelines for radiation therapy in pediatric metastatic RMS.
- To provide evidence-based recommendations for local treatment strategies.
- To assist healthcare providers in optimizing care for pediatric RMS patients.
Main Methods:
- The INSTRuCT radiation oncology committee formulated guidelines based on evidence quality.
- Guidelines consider disease burden, location, and available local therapy options.
- Focus is placed on radiation techniques for effective local control.
Main Results:
- Definitive therapy to the primary site and regional lymph nodes is recommended post-neoadjuvant chemotherapy for metastatic RMS.
- Local treatment of all disease sites is advised when feasible.
- Radiation dose and modality decisions should incorporate disease characteristics and patient prognosis.
Conclusions:
- Limited evidence exists, but consensus positions offer guidance for pediatric metastatic RMS treatment.
- These guidelines support providers in complex treatment decisions.
- The recommendations aim to improve outcomes for children with metastatic RMS.
Purpose:
The International Soft Tissue Sarcoma Database Consortium is a collaboration of the North American and European pediatric oncology cooperative groups that aims to provide treatment recommendations for pediatric patients' sarcoma diagnoses.
Methods And Materials:
The International Soft Tissue Sarcoma Database Consortium radiation oncology committee has developed international consensus guidelines for the use of radiation for local therapy in pediatric patients with metastatic rhabdomyosarcoma (RMS) based on grade and quality of evidence. Specifically, the guidelines address management based on disease burden, disease location, and local therapy options that focus on radiation techniques.
Results:
Patients who present with metastatic RMS at initial diagnosis should be strongly considered for definitive therapy to the primary site and radiation to involved regional lymph nodes after neoadjuvant chemotherapy. When feasible, local treatment of all sites of disease is recommended. Evaluation of the location, size, and extent of disease and patient prognosis should be used when deciding which radiation dose and modality therapy is most appropriate for metastatic disease.
Conclusions:
Although the evidence is limited, these consensus guidelines highlight consensus positions regarding the best practice treatment to assist providers as they navigate treatment decisions for their pediatric patients with metastatic RMS.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
